CNBC: Eli Lilly says next-generation weight loss drug clears crucial obesity trial

 

CNBC: Weight-loss wars go global as Novo Nordisk bets big on its Wegovy pill

 

Why Barrière Thinks You’ll Want To Wear You Vitamins

 

The Explosive Rise of Unapproved Peptide Injections

 

Η Angelini Pharma εξαγοράζει την Catalyst Pharmaceuticals

 

Η Angelini Pharma εξαγοράζει την Catalyst Pharmaceuticals για 4,1 δισεκατομμύρια USD(3,5 δισεκατομμύρια ευρώ), εισέρχεται στην αγορά των ΗΠΑ και εδραιώνει την ηγετική της θέση στον τομέα της υγείας του εγκεφάλου και των σπάνιων παθήσεων

·         Τα Διοικητικά Συμβούλια της Angelini Pharma και της CatalystPharmaceuticals ενέκριναν ομόφωνα...

Why GLP-1s Are Helping The Hair Care Industry

 

Goop Kitchen, Ozempic Breath, Hotspan | BTW: Headlines You Should See

 

J&J’s New Drug for Treatment-Resistant Depression

 

Tylenol in pregnancy not linked with autism, Danish study finds

 

Free Expression on the Weekend: Louise Perry on Dopamine Dysfunction

 

CNBC: Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era

 

How Thorne Became One Of Gen Z's Favorite Wellness Brands

 

Tailor-made: The world’s first personalized gene-editing treatment

 

Want to Improve Your Health? Stop Adding and Start Subtracting

 

Scientists develop artificial corneas from fish scales | DW News

 

CNBC: Zealand CEO hits out at ‘weight loss Olympics’ after trial results send stock tumbling over 35%

 

G: UK’s private dentistry market faces review after price jumps of up to 23%

 

G: Wegovy and Ozempic owner dealt blow as next-gen weight-loss drug is labelled ‘obsolete’

 

What's Stopping GLP-1s From Getting Cheaper

 

Tea May Be Nicer to Your Bones Than Coffee, Study Suggests